World Dental Implant and Bone Graft Market to Top $4.5 Billion by ...
PR Leap (press release) - Chula Vista,CA,USA
COM) New York, May 15, 2007— Global sales of dental implant systems, fast becoming the preferred restoration for replacement of missing or extracted teeth ...
See all stories on this topic

Implant reimbursement
Dental Economics - Tulsa,OK,USA
It is my overall intention to assist your practice in streamlining the DENTAL REIMBURSEMENT PROCESS for the treatments you perform. ...
See all stories on this topic

Implant reimbursement
Dental Economics - Tulsa,OK,USA
The most common of all dental implant procedures is the endosteal procedure. According to CDT, procedure code D6010 includes the surgical placement of the ...
See all stories on this topic

Biomet to Be Bought by Equity Group for $10.9 Billion (Update6)
Bloomberg - USA
... A sale of the dental implant business, which Biomet bought in 1999 for $175 million, may generate as much as $1.7 billion, Weinstein said. ...
See all stories on this topic

Sun-Sentinel.com - Fort Lauderdale,FL,USA
... Thursday. 3i, a developer of dental implant products in Palm Beach Gardens, won the state award for export excellence. Jupiter-based ...

Research team to study effects of bone health on dental implants
UConn Advance - Storrs,CT,USA
... “Evidence suggests that bone disorders such as osteoporosis may compromise the success of dental implant placements that require preliminary bone building ...

The Oconomowoc Focus
Oconomowoc Focus - Oconomowoc,WI,USA
... Dental implants can also be the more expensive solution for adults with missing teeth. Placing and restoring a single implant can cost about $3,000, on average ...

Business Buzz
Daily Hampshire Gazette (subscription) - Northhampton,MA,USA
... DeMaio specializes in early treatment, invisible braces and implant aided orthodontics. He is a member of the American Dental Society, American Association of ...

Nanotechnology-Based Medical Anti-Friction Coating
Nanotechnology News (press release) - USA
... friction in implants, such as artificial joints, extensively prolonging implant's life and ... and Alon Katz (both from the Faculty of Dental Medicine, Hebrew ... 

Nobel Biocare and the University of Maryland Dental School
PrimeZone (press release) - Los Angeles,CA,USA
In 1965, the first patient was treated with the original scientific dental implant system, Nobel Biocare's Branemark System(r). For 40 years, Nobel Biocare has

Dental implants simplify
Cincinnati Enquirer - Cincinnati,OH,USA
The 65-year-old Indian Hill resident invented the "Replace Select" dental implant system - a system for replacing missing teeth with artificial ones that have

Dental Care Tips From Crest.com
Pittsburgh Channel.com - Pittsburgh,PA,USA
and antiseptically superior dental care. Dr. Medgaus has completed numerous continuing education courses in Aesthetic dentistry, Implant Dentistry, Light force

(PZ) Nobel Biocare Consumer Awareness Campaign NobelSmile Now
Houston Chronicle - United States
inform about the fantastic possibilities that dentists and dental laboratories can ... enhancing, beautiful tooth restoration solutions, be it implant solutions or

A fishy business... but this diving lark is a very rewarding
Sunderland Echo - UK
off Mexico. Fiona, 37, manager for a dental implant company, said: The sea life is amazing. It is just a different world.". She and

UK's 'dental tourists' drive boom
BBC News - UK
A dental implant - a metal screw placed into the jaw bone to hold a replacement tooth or bridge - costs £1,000 - £2,000 at my dentist's in north London.

Nobel Biocare says new research shows 'no unusual bone loss' from
Forbes - USA
STOCKHOLM (AFX) - Swiss-Swedish dental implant company Nobel Biocare AB said four scientific publications will shortly publish research showing no unusual bone
See all stories on this topic

Revolutionary Product: The Atlantis Abutment in Zirconia with
Business Wire (press release) - San Francisco,CA,USA
CAMBRIDGE, Ma.--(BUSINESS WIRE)--March 17, 2006--Atlantis Components, Inc., innovator in the dental implant market, announces the launch of the Atlantis

Dental implant research, education to benefit from donation
UConn Advance - Storrs,CT,USA
and Reconstructive Dentistry has received a $500,000 gift from Straumann USA to expand its curriculum in the rapidly growing field of dental implant therapy.

BioLok International Products Recognized for Superior Stability in
PR Newswire (press release) - New York,NY,USA
Dental Implant System Strength and Structure Studied at University of Medicine & Dentistry of New Jersey DEERFIELD BEACH, Fla., Feb.
See all stories on this topic

Nobel Biocare 'resolutely disputes' new bone loss allegations
Forbes - USA
GOTHENBURG, Sweden (AFX) - Swedish dental implant maker Nobel Biocare AB said it 'resolutely disputes' new allegations, published by a financial analyst
See all stories on this topic

Euroshares turn lower as oils fall on Shell woes, Astrazeneca FY
Forbes - USA
as Merrill Lynch issued a note which said a study has shown there is greater than expected bone loss in patients using the Nobelperfect dental implant, one of

St. Clair: Facts on restoration
Georgetown Record - Beverly,MA,USA
However, because dental restorations are replacements for natural teeth, potential problems ... potential exists for the fracture of an implant component, implant

Swiss shares close higher on gains by heavyweights UPDATE
Forbes - USA
down 3.75 at 284, extending losses seen yesterday after a study said its NobelPerfect product causes excessive bone loss, a claim the dental implant maker was
See all stories on this topic

Nature Suggests a Layered Composite for Artificial Bone
NETCOMPOSITES - Chesterfield,UK
larger structures, hopefully one day advancing to the design of a hip implant. ... The National Institute of Dental and Craniofacial Research (NIDCR) is part of

Annual Implant Industry Report 2002

The Annual Implant Industry Report is prepared by Millennium Research Group. It is a 300 Page in-depth market report on dental implants. Implant Dentistry (Volume 12 / Number 2/ 2003) has published the Executive Summary of this report. You can find the report in the journal starting on page 108 and you can read the PDF right here. You may also view their reoprt on the current state of Bone Graft Substitutes.

Sulzer Medica announced today the purchase of all the business related assets of Core-Vent Bio-Engineering and Core-Vent Corporation, collectively doing business as Paragon Implant Company ("Paragon"), for a purchase price of USD 100 Million. The acquisition will double the market share of Sulzer Medica, positioning it among the top three in sales of dental implants worldwide, while providing significant strategic, product and sales synergies. Sulzer Medica's current dental implant company, Sulzer Calcitek, and Paragon will merge to become Sulzer Dental, headquartered in Carlsbad, CA.

Annual Implant Industry Report

The Annual Implant Industry Report is prepared by Millennium Research Group. It is a 300 Page in-depth market report on dental implants. Implant Dentistry (Volume 9 / Number 3/ 2000) has published the Executive Summary of this report. You can find the report in the journal starting on page 192 and you can read my summary of the report by Clicking here.

LAS VEGAS, NEVADA, 26 JULY 2000

Paragon and Friadent Settle

Dr. Gerald A. Niznick, President of Core-Vent Corporation (DBA Paragon Implant Company), and Dr. Freimut Vizethum, President of Friadent North America, Inc., announced today that Core-Vent Corporation and Friadent North America, Inc. have entered into a confidential settlement of all patent litigation pending between them.

Friadcnt North America, Inc. has acknowledged that Core-Vent Corporation's United States Patent No. 4,960,381 is valid and infringed by its internal hex implants. Core-Vent Corporation has granted Friadent North America, Inc. a limited license on its existing and future implant designs.

Both companies were pleased to reach an amicable end to the controversy between them.

August 30, 1999

Biomet and Implant Innovations Inc. Announce Agreement to Merge

WARSAW, Ind.--(BW HealthWire)--Aug. 30, 1999--Biomet, Inc. (Nasdaq:BMET) today announced a definitive agreement has been reached providing for the merger of Biomet with Implant Innovations Inc.

("3i"), a leader in the global dental implant market. Under terms of the agreement, Biomet will acquire all of 3i's outstanding shares in a stock-for-stock merger transaction intended to be accounted for as a pooling-of-interests. The transaction is valued at approximately $175 million and is expected to be completed by November 30,1999.

Dr. Richard Lazzara and Keith D. Beaty founded 3i, based in Palm Beach Gardens, Florida, in 1987. 3i designs, manufactures and markets a comprehensive line of dental implant products which offer an alternative to crowns and bridges for patients. A dental implant is a small titanium screw that is surgically placed directly into the jaw and serves as the foundation for a replacement tooth. 3i also distributes regenerative membranes and bone graft materials. 3i's customers include oral surgeons, periodontists, prosthodontists and dentists who perform dental implant procedures.

3i is a leader in the $575 million worldwide dental implant market with a strong track record of increasing its market share. 3i generated revenue of approximately $70 million in calendar year 1998, an increase of approximately 29% over calendar year 1997. 3i's introduction of its Osseotite(R) surface technology incorporated in dental implants has benefited patients and clinicians by reducing the healing time and increasing the predictability of the implant's success.

Dane A. Miller, Ph. D., President and Chief Executive Officer of Biomet, said, "This is the largest acquisition in Biomet's history and we welcome Keith D. Beaty and Dr. Richard Lazzara as well as the approximately 400 3i team members to the Biomet team. 3i's strong direct distribution network in the United States and Europe in addition to its presence in other major international markets provides an excellent complement to Biomet's expanding orthopedic and craniomaxillofacial product lines and positions us to capitalize on product and marketing opportunities in the $10 billion worldwide market for musculoskeletal implants and accessories. Moreover, the combination will provide 3i with greater resources to facilitate its future growth plans in the burgeoning dental implant market."

3i's President and CEO, Keith D. Beaty, commented "The fit with Biomet is tremendous. We will benefit from Biomet's expertise and broad platform in biomaterials research and medical device technologies. We have created a leading dental implant company and we are excited about the possibilities of the combination with Biomet to advance our position within the global dental implant marketplace. We think this combination will benefit clinicians utilizing the 3i system by providing products and services backed by the synergies of a leading medical technology team."

The agreement is subject to certain collar provisions. The number of Biomet shares to be issued is designed to provide $175 million in aggregate value for 3i, subject to a minimum of 4.0 million Biomet common shares and a maximum of 5.2 million Biomet common shares in exchange for the stock of 3i. Excluding transaction expenses and anticipated synergies, the transaction is expected to be slightly accretive to Biomet's current year earnings per share and to become increasingly accretive in the following years.

Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by orthopedic medical specialists in both surgical and non-surgical therapy, including reconstructive and fixation devices, electrical bone growth stimulators, orthopedic support devices, operating room supplies, spinal implants, general surgical instruments, arthroscopy products, bone cements, bone substitutes and craniomaxillofacial implants and instruments. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 100 countries.

For further information contact Greg W. Sasso, Vice President, Corporate Development and Communications at (219) 372-1528.

Web site: www.biomet.com or e-mail investor.relations@biometmail.com

July 5, 1998

The Nobel Biocare Purchase of Steri-Oss . . .

I have been following this one very closely. On the surface, it seems like Nobel Biocare has done a total 180 degree turn around from their philosophy of implant dentistry, but after taking a closer look, Here's the way I see it:

1. Nobel Biocare has finally realized that if it wants to prosper in this field, it is going to have to start meeting the needs of more of the dentists out here, not just a few of the "Elite". While it may have hurt their pride (of which they have much too much) to take the plunge, it is definitely good business.

2. I think that Nobel Biocare's plan will include making a huge public campaign for implant dentistry. This is something that I pitched to the company almost 10 years ago and I'm glad to see that it will finally be coming to fruition. The net result here will be to re-stimulate the public's interest in implant dentistry and that has to be good for everyone. Other companies have looked into going to the public recently. Sterngold actually ran a test campaign in the Washington DC area, but their entire concept was poorly conceived and ended as a total failure. Nobel Biocare with the Steri-Oss segment now has the clout and the resources to do this properly and I can't wait....

BTW... Don't worry about not using there product when this advertising campaign hits the streets, there will be plenty of opportunity for the local practitioners to piggy back on the campaign. Patient's do not put much stock in product recognition when compared to the opinion of their own dentists....

3. While there is no sign of Nobel Biocare lowering their prices, I think that this will all lead to lower costs for Implantology hardware and lower fees to patients. When you start to have companies merging together with very different product lines, it tens to smooth out the overall differences in systems. I think we will less of "my implant is better than yours" and more of a level field competition.

4. While Nobel Biocare has been a champion of the specialist in implant dentistry, it can readily be seen how their tune is changing with their simplified dentistry campaign which is aimed squarely at the general practitioner. The general practitioners have to become more involved in implant dentistry in order for it to reach it's true potential.

And while it is all for the best for the dentists and the patients, I can't help poking a little fun at the stodgy old Nobel Biocare's out there. So here Nobel Biocare before and after....

BEFORE: The Nobel Pharma company is the only one who knows how to really make dental implants.

AFTER: It looks like all manufacturing will now be done out of Steri-Oss's California Plant:

BEFORE: Screw retained restorations are the only way to go.

AFTER: There will definitely now be an emphasis on cemented restorations:

BEFORE: Pure Titanium - No coatings

AFTER: Whatever you want on your implant (Mustard and Catsup????).

BEFORE: Specialist exclusivity.

AFTER: Promotion of the general dentist as the mainstay of Implant Dentistry

(OK that last one is a prediction... But that's the way it's going...).

June 29, 1998
Nobel Biocare has just entered into an agreement to purchase Steri-Oss. Bausch & Lomb had purchased Steri-Oss several years ago, but lost a ton of money on them and eventually sold the company back to the original owners. Now it's Nobel Biocare's turn...